TheStreet is providing FREE access to Jim Cramer’s charitable trust (Action Alerts PLUS) and his premium articles on Real Money this weekend. Please register here.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.



) -- Would you rather own a winner or a whiner? Jim Cramer asked on 

Mad Money

 Tuesday. Cramer sounded off against all those companies complaining a

strong U.S. dollar

 ruined their quarterly results. Cramer said it's time to throw out the whiners and buy the winners at a great price.

Who are these whiners? Cramer said Microsoft (MSFT) - Get Microsoft Corporation (MSFT) Report , a stock he owns for his charitable trust, Action Alerts PLUS, turned out to be one of them. The company complained about weak sales in China and Japan, sending shares down 9%. Other whiners included Procter & Gamble (PG) - Get Procter & Gamble Company Report , down 3.4%, FreeportMcMoran (FCX) - Get Freeport-McMoRan, Inc. (FCX) Report , down 6% and the biggest whiner of them all, Caterpillar (CAT) - Get Caterpillar Inc. Report , down 7%.

Cramer said he's taking a pass on the "whine bar" and sticking with the winners. If Procter is losing sales, those sales must be going to Action Alerts PLUS holding Unilever (UL) - Get Unilever PLC Sponsored ADR Report , based in Europe, or Kimberly-Clark (KMB) - Get Kimberly-Clark Corporation (KMB) Report .

Cramer is also a fan of domestic winners including Apple (AAPL) - Get Apple Inc. (AAPL) Report , another Action Alerts PLUS holding, and Yahoo! (YHOO)  along with Kroger (KR) - Get Kroger Co. (KR) Report , Southwest Airlines (LUV) - Get Southwest Airlines Co. Report and just about any of the biotech names including Regeneron (REGN) - Get Regeneron Pharmaceuticals, Inc. Report .

More Winners

The markets are driving down the prices of just about every international company as investors attempt to get ahead of real, or perceived, currency problems, Cramer said. But that may create opportunities, if you know where to look.

Case in point: Boeing (BA) - Get Boeing Company Report . Cramer said the demand for planes is still strong and military spending around the globe is on the rise. But with 43% of Boeing's sales stemming from overseas, there's a good chance the company might report some currency weakness. Fortunately, shares of Boeing have already come down ahead of earnings, making an attractive entry point.

Cramer said Pepsico (PEP) - Get PepsiCo, Inc. Report also fits this pattern, a strong company with falling shares.

What other companies can be bought? Cramer said he likes those that triumphed over currency issues, companies such as Honeywell (HON) - Get Honeywell International Inc. (HON) Report and Starbucks (SBUX) - Get Starbucks Corporation Report , another Action Alerts PLUS holding. Then there are the stocks that have already "reset" to the new expectations, stocks like Kimberly-Clark.

Executive Decision: Scott Wine

For his "Executive Decision" segment, Cramer spoke with Scott Wine, chairman and CEO of Polaris Industries (PII) - Get Polaris Inc. Report , which rallied 5.4% on strong quarterly results.

Wine noted that while Polaris delivered strong results for the quarter, he also said, "We can do better." Polaris can execute even better and manage inventory even better, Wine continues.

While Polaris did see significant currency pressures in the quarter, more important for the company was continued innovation. Wine said the company plans on continuing its fierce innovation, delivering higher-quality products to customers even faster and with higher gross margins.

When asked whether this week's record snowstorms in the Northeast helped drive sales, Wine confirmed that the more snow there is, the better for Polaris.

Cramer said Polaris' stock has been under pressure for no reason and he wants viewers to "have faith" in the company.

TheStreet Recommends

Off the Charts, Super Bowl Edition

In a Super Bowl edition of his "Off The Charts" segment, Cramer went head to head with colleague Bob Lang to pit four Seattle-based companies, Costco (COST) - Get Costco Wholesale Corporation Report , Nordstrom (JWN) - Get Nordstrom, Inc. (JWN) Report , Microsoft and Starbucksagainst four New England-based companies, Boston Beer (SAM) - Get Boston Beer Company, Inc. Class A Report , CVS Health (CVS) - Get CVS Health Corporation Report , Skyworks Solutions (SWKS) - Get Skyworks Solutions, Inc. Report and Dunkin Brands (DNKN) - Get Dunkin' Brands Group, Inc. Report .

In the first matchup between Costco and Boston Beer, Lang noted Costco has a nice floor of support while Boston Beer is in overbought territory and is likely to take a rest. In this matchup, Costco wins.

Next, Lang said Nordstrom is in a solid uptrend and has a nice entry point. CVS is also rallying strong with tremendous performance. In a close matchup, Lang gave the edge to Nordstrom.

In the next contest, Lang said today's breakdown of Microsoft sent it below its 200-day moving average, meaning it will likely trade sideways. Skyworks, however, has been rallying on strong volume. Advantage Skyworks.

Finally, Lang called Starbucks the winner among the coffee group, noting a strong MACD momentum indicator and a recent gap higher with no resistance above its all-time high. Meanwhile, Dunkin has seen a strong rally since December but also displays the dreaded head-and-shoulders pattern.

With a final score of Seattle three, New England one, Cramer declared his stock market winners.

Lightning Round

In the Lightning Round, Cramer was bullish on First Horizon National (FHN) - Get First Horizon National Corporation Report .

Cramer was bearish on State Street (STT) - Get State Street Corporation Report , Achillion Pharmaceuticals (ACHN) - Get Achillion Pharmaceuticals, Inc. Report and Martin Midstream Partners (MMLP) - Get Martin Midstream Partners L.P. Report .

Executive Decision: Tim Walbert

In his second "Executive Decision" segment, Cramer spoke with Tim Walbert, chairman, president and CEO of Horizon Pharmaceuticals (HZNP) - Get Horizon Therapeutics Public Limited Company Report , a small biotech company with five drugs on the market, four of which stemmed from smart acquisitions.

Walbert said Horizon's recent acquisitions have been very exciting because his company is able to provide focus to drugs that were lost when part of bigger pharma companies.

Walbert also touted Horizon's "Prescriptions Made Easy" program that aims to do the right thing for patients by making treatments easier to access and more affordable when needed.

In addition to helping to widen distribution of its drugs, Horizon is also actively developing them to treat new indications, with some exciting Phase III studies currently underway.

Cramer said Horizon is a niche player that has a lot of positive things going for it.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter


or get updates on Facebook,


At the time of publication, Cramer's Action Alerts PLUS had a position in AAPL, MSFT, SBUX and UL.